Clinical Study
Survival Prediction Score: A Simple but Age-Dependent Method Predicting Prognosis in Patients Undergoing Palliative Radiotherapy
Table 1
Patient characteristics.
| Characteristic | Number | % |
| Entire cohort | 579 | | Age (years) | | | <60 | 96 | 16.6 | ≥60 | 483 | 83.4 | Gender | | | Male | 356 | 61.5 | Female | 223 | 38.5 | Karnofsky performance status1 | | | 90–100 | 75 | 13.0 | 70–80 | 160 | 27.6 | ≤60 | 343 | 59.2 | Primary tumor site | | | Prostate | 145 | 25.0 | Breast | 67 | 11.6 | Lung (small cell) | 31 | 5.4 | Lung (nonsmall cell) | 105 | 18.1 | Colorectal | 37 | 6.4 | Pancreas | 9 | 1.6 | Bladder | 32 | 5.5 | Other | 153 | 26.4 | Number of RT fractions | | | 1–4 | 114 | 19.7 | 5–9 | 140 | 24.2 | 10 | 210 | 36.3 | 11–15 | 90 | 15.5 | >15 | 25 | 4.3 | Dose per fraction (Gy) | | | <3 | 60 | 10.4 | 3 | 262 | 45.3 | 3.1–3.9 | 16 | 2.8 | 4 | 125 | 21.6 | 4.1–5 | 26 | 4.5 | >5 | 90 | 15.5 | Selected target types | | | Bone metastases | 314 | 54.2 | Brain metastases | 68 | 11.7 | Lymph node metastases | 34 | 5.9 | Brain metastases1 | | | No | 483 | 83.4 | Yes | 92 | 15.9 | Liver metastases1 | | | No | 459 | 79.3 | Yes | 116 | 20.0 | Lung metastases1 | | | No | 451 | 77.9 | Yes | 124 | 21.4 | Adrenal gland metastases1 | | | No | 518 | 89.5 | Yes | 57 | 9.8 | Bone metastases1 | | | No | 194 | 33.5 | Yes | 381 | 65.8 | Systemic cancer treatment1 | | | No | 256 | 44.2 | Within 4 weeks before RT | 118 | 20.4 | Within 3 months before RT | 69 | 11.9 | Earlier | 79 | 13.6 |
|
|
RT: Radiotherapy. Missing information in some cases.
|